Bridgeway Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-91,170
Closed -$15.9M 1386
2020
Q4
$15.9M Sell
91,170
-36,404
-29% -$6.29M 0.34% 86
2020
Q3
$20.6M Buy
127,574
+116
+0.1% +$18.4K 0.47% 59
2020
Q2
$18.2M Buy
+127,458
New +$17.6M 0.37% 94

Other funds holding LH

Bridgeway Capital Management's LH Position: Q1 2021 in Review

Bridgeway Capital Management sold out of Labcorp (LH) in Q1 2021, closing a stake of 91,170 shares — an estimated $15.9M sold.

Bridgeway Capital Management first reported a position in LH in Q2 2020 and held it in 3 quarters. The position peaked at $20.6M in Q3 2020. 920 funds tracked by Wall St. Rank hold LH as of Q1 2021.

  • Bridgeway Capital Management reported no remaining Labcorp position as of Q1 2021 after selling out during the quarter.
  • Bridgeway Capital Management sold 91,170 Labcorp shares in Q1 2021, an estimated $15.9M.
  • Bridgeway Capital Management first reported a position in Labcorp in Q2 2020 and held it in 3 quarters.
  • Bridgeway Capital Management's Labcorp position peaked at $20.6M in Q3 2020.
  • 920 funds tracked by Wall St. Rank held Labcorp as of Q1 2021.

Based on Bridgeway Capital Management's 13F filing for Q1 2021, filed 17 May 2021.